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Introduction: Both supported and unsupported bifurcated endograft limbs develop flow-restricting lesions, including
kinks, stenoses, and occlusions, which can be identified during or after surgery. Recognition and intervention are essential
to achieve long-term graft patency and a satisfactory functional result. This report represents a comprehensive
retrospective review of graft limb interventions from the Phase II EVT Trial with the Endovascular Grafting System
unsupported bifurcated endograft (Guidant/EVT, Menlo Park, Calif).
Methods: The study population consists of 242 patients who underwent treatment with bifurcated endografts implanted
during the EVT Phase II Trial. Graft limb interventions have been divided into two groups: those in whom the
intervention occurred during surgery versus those in whom the intervention occurred after surgery. Parameters studied
included type, incidence, and timing of graft limb intervention, indications for intervention, procedures performed, and
overall patient outcome.
Results: The mean follow-up period was 31 months. Primary, primary assisted, and secondary limb patency rates were
61.6%, 93.7%, and 97.1%, respectively. Technical success rate at case completion was 97.5%. In 68 of the 242 cases, limb
interventions were performed during surgery to assure patency (28.1%). In 28 cases, interventions were performed after
surgery (11.6%). Of these postoperative limb problems, 82% occurred during the first 6 months. Repeat limb
interventions were necessitated in three patients (1.2%). Within the intraoperative intervention group, perceived
indications included kinks (15%), stenosis (57%), dissection (6%), graft redundancy (12%), and instances of twists,
thrombosis, and pressure gradients (10%). These findings were successfully managed with percutaneous transluminal
angioplasty only (41%), percutaneous transluminal angioplasty and stent (50%), and various combined interventions.
Within the postoperative intervention group, symptomatic indications included stenosis (46%) and thrombosis/
occlusion (54%). These postoperative limb events were successfully managed with stent (64%), thrombolysis (32%), and
femoral-femoral bypass (21%). When limb dysfunction developed in the postoperative setting, it most often occurred
within the first 6 months of implantation. Only one patient in this Phase II cohort had a lower extremity amputation
unrelated to a graft limb abnormality.
Conclusion: The unsupported bifurcated limbs of this endograft necessitated primary adjunctive intervention in 40% of
cases. Primary intervention was two times more likely to be performed at the time of the implant rather than after surgery.
Repeat limb interventions were not common. Endograft limb flow problems were successfully treated with standard
endovascular or surgical interventions or both. These data may support prophylactic stenting of unsupported Ancure
graft limbs. A strategy that includes both intraoperative and early postoperative graft limb surveillance is essential to
detect reduced limb flow. (J Vasc Surg 2002;36:118-26.)
The design of the Endovascular Grafting System bifur-
cated endograft (Guidant/EVT, Menlo Park, Calif) in-
cludes proximal and distal hook fixation and no stent
support within its limbs. The resulting design features have
potential unique strengths and problems. With the sharp
elgiloy hooks at each end, fixation at the proximal and distal
attachment sites is enhanced, potentially decreasing migra-
tion problems. The unsupported endograft body and legs
made of polyester fabric theoretically may respond favor-
ably to morphologic changes occurring within the aneu-
rysm sac after implantation. However, although endograft
migration has not been an issue with this particular en-
dograft, the unsupported endograft limbs are vulnerable
and can develop flow-restricting lesions in association with
heavily calcified aortic bifurcations, stenotic, tortuous or
angulated common iliac arteries, and graft oversizing. Not
only narrow calcified rigid aortic bifurcations but also small
angulated origins of the common iliac arteries may result in
kinking problems. In the presence of such anatomy, im-
plantation of an aortouniiliac graft may be indicated rather
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than an attempt to accommodate two limbs through a
narrow calcified angulated orifice. This endograft has a
short body, such that after deployment, the endograft
bifurcation resides high above the native aortic bifurcation,
resulting in the potential for compression and kinking of
the limbs, particularly in the presence of a small rigid aortic
bifurcation. These resulting limb kinks, twists, and redun-
dant fabric pleats can produce stenoses and occlusions that
may be perceived during surgery but that may also present
in a delayed fashion after surgery (Figs 1 to 3).1-6
The Endovascular Grafting System endograft under-
went design modifications to the delivery/deployment sys-
tem without changing the endograft itself in 1998 and was
renamed the Ancure endograft system. The US Food and
Drug Administration approved the Ancure endograft on
September 28, 1999, and since then, more than 2000
physicians have been trained in the United States to implant
the device.
Recognition of the potential for limb dysfunction both
during and after surgery and prompt intervention by phy-
sicians implanting the Ancure endograft is essential to
achieve long-term graft limb patency and a satisfactory
functional result. This report represents the first compre-
hensive retrospective review of graft limb interventions
from the Phase II EVT Trial. On the basis of the data
presented in this work, the authors intend to develop a set
of recommendations relevant to graft limb deployment and
follow-up.
METHODS
We reviewed the records of 242 patients who under-
went treatment at 18 centers during the US Food and Drug
Administration-approved Phase II Trial from December
20, 1995, to February 15, 1998. This report only includes
patients who received bifurcated endografts and excludes
patients treated with tube or aortouniiliac endografts. The
mean follow-up period was 31 months. Preoperative assess-
ment included marker catheter arteriograms and unen-
hanced and 3-mm cut enhanced computerized tomo-
graphic scans of the abdomen and pelvis. Patient
enrollment into the trial was on the basis of an intent-to-
treat design analysis. Criteria for patient selection were
Fig 1. A, Preoperative arteriogram. B, Intraoperative arteriogram after deployment. Arrow points to compression of
left limb by aortic bifurcation. C, Placement of bilateral Wallstents. D, Completion arteriogram.
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largely on the basis of anatomic issues, but subjects also
were required to provide informed consent and have anes-
thesia clearance and a 2-year life expectancy. The anatomic
parameters are summarized in Table I. The primary inves-
tigators decided on individual patient enrollment, although
film reading and sizing were done in Menlo Park. Interven-
tions for graft limb dysfunction have been divided into two
groups: those in whom the intervention occurred during
surgery versus those in whom the intervention occurred
after surgery. Repeated interventions were performed for
recurrent episodes of reduced limb flow. In addition, we
calculated the primary, primary assisted, and secondary
patency rates. However, that primary intraoperative inter-
ventions for perceived reduced graft limb flow represent a
phenomenon that is not strictly comparable with the pri-
mary assisted patency of other arterial bypass grafts must be
kept in mind. In addition to the timing and incidence of
graft limb dysfunction, the other focused outcome param-
eters examined included specification of each type of limb
abnormality, type and frequency of interventions, overall
patient outcome, and identification of variables predictive
of graft limb dysfunction.
RESULTS
At a mean follow-up period of 31 months, overall
primary patency was obtained in 149 of 242 cases (61.6%).
Of all cases, 76 of 242 (31.4%) had either perceived or
objectively measured reduced limb flow that prompted an
intervention, either during or after surgery. Thus, a primary
assisted patency rate of 93.7% was achieved at 31 months of
follow-up. Seventeen of 242 cases (7%) had a thrombosed
limb either during or after surgery. Flow was successfully
restored after secondary intervention in 10 of those 17
cases, thus yielding an overall secondary limb patency rate
of 97.1%. In 68 of the 242 cases (28.1%), limb interven-
tions were performed during surgery to assure patency at
the completion of the case. Technical success was defined as
adequate bilateral limb patency without conversion to open
techniques, such as thrombectomy, retroperitoneal limb
exposure/suture, or femorofemoral bypass. Within the in-
Fig 2. A, Arrow points to redundant fabric pleats in left limb after deployment. Right limb still has delivery system in
place, so blood flow is obstructed. B, Resolution after placement of Wallstent. C, Another patient with tortuous
angulated right common iliac artery on preoperative arteriogram. D, Right limb twist after deployment and removal of
stiff wires.
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traoperative intervention group, perceived indications in-
cluded kinks (15%), stenosis (57%), and dissection (6%) and
graft redundancy (12%). In addition, obvious instances of
twists, thrombosis, and pressure gradients occurred in 10%.
Intraoperative findings were successfully managed with
percutaneous transluminal angioplasty only (41%), percu-
taneous transluminal angioplasty/stent (50%), and various
open/endovascular combined interventions (Fig 4). At the
completion of the case including any needed intraoperative
endovascular interventions, technical success was achieved
in 236 of 242 cases (97.5%). Four patients needed open
retroperitoneal suture repair of one of the endograft limbs,
one patient needed thrombectomy of one of the limbs, and
one patient needed a femorofemoral bypass after failed
endovascular attempts at obtaining adequate limb patency
(Fig 4).
In 28 cases (11.6%), interventions were performed after
surgery to treat symptoms, measured flow problems, or
Fig 3. A, Right limb stenosis 3 weeks after implantation in patient with claudication. B, Resolution with Wallstent
placement. C, Another patient with angulated left common iliac artery on preoperative arteriogram. D, Patient was seen
with claudication and left limb occlusion 4 weeks after implantation.
Table I. Anatomic considerations for endovascular abdominal aortic aneurysm repair
Anatomy Graft type Requirement
Superior neck All Aortic superior neck 26 mm in diameter and 15 mm in length, with 45-degree
angulation and without circumferential calcification or circumferential atheroma
Inferior neck Tube Aortic inferior neck 26 mm in diameter and 12 mm in length
Access vessels All At least one femoral or iliac artery permitting access with 23.5F (7.9-mm) device, with
60-degree iliac angulation and without circumferential iliac calcification or atheroma
Iliac attachment sites Bifurcated Both iliac vessels having healthy segments 20 mm in length and 13.4 mm in diameter;
contralateral femoral artery or iliac artery permitting access with 12F (4.0-mm) device
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limb thromboses. Of these postoperative limb problems,
82% occurred during the first 6 months. Repeated limb
interventions were necessitated in only three patients
(1.2%). Postoperative interventions were performed for
symptoms that included stenosis (46%) and thrombosis/
occlusion (54%). These 28 postoperative limb events were
successfully managed with stent (64%), thrombolysis
(32%), and femorofemoral bypass (21%). Several patients
underwent more than one approach in the management of
limb flow problems (Fig 5). Thus, only seven patients in the
entire series (2.9%) needed a femorofemoral bypass graft
(one during and six after surgery). Three patients under-
went primary femorofemoral bypass for limb occlusion
without an initial endovascular approach. When limb dys-
function developed in the postoperative setting, it most
often occurred within the first 6 months of implantation.
Only one patient in this Phase II cohort had a lower
extremity amputation, and this patient did not have an
endograft limb abnormality. Repeated limb interventions
were necessary in three patients (1.2%). One patient in this
Phase II cohort had a lower extremity amputation that
occurred in the early postimplantation period but was not
associated with graft limb dysfunction. Table II provides
the results of a multivariate logistic regression analysis
performed to identify variables predictive of reduced graft
limb flow and dysfunction. Two variables showed a signif-
icant statistical correlation predictive of graft limb dysfunc-
tion: female gender (P  .002) and graft limb diameter
oversizing by 3.5 to 4.4 mm relative to the common iliac
artery attachment site. This degree of graft diameter over-
sizing increased the risk of limb dysfunction necessitating
intervention by 12 fold (P .011; Table III). The presence
of coexistent infrainguinal arterial occlusive disease showed
a trend toward increased risk for graft limb dysfunction
(P  .080). A statistically significant correlation was seen
between the number of implants performed at a center
(case volume) and the percentage of intraoperative inter-
ventions (Spearman rank correlation coefficient, r 0.606;
Fig 4. Interventions performed during surgery: indications and techniques.
Fig 5. Interventions performed after surgery: indications and techniques.
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P  .008; Fig 6). Other potential correlations, including
case volume versus the percentage of postoperative inter-
ventions and percentage of intraoperative interventions
versus postoperative interventions per center, were not
statistically significant (Figs 7 and 8).
DISCUSSION
This review of endograft limb problems during Phase II
EVT clinical trials shows that unsupported bifurcated limbs
received primary adjunctive interventions in approximately
40% of cases. Primary intervention was two times more
likely to be performed at the time of implant for perceived
limb dysfunction rather than after surgery for symptomatic
limb dysfunction. Standard endovascular approaches were
frequently successful in the intraoperative setting and took
the form of supplemental angioplasty and stents in 90% of
cases. When limb dysfunction developed in the postopera-
tive setting, it most often occurred within the first 6 months
after implantation. Although postoperative instances of
limb dysfunction were similarly managed with endovascular
approaches (stents) in 60% of cases, both thrombolytic
therapy and surgical revision with femorofemoral bypass
were used in cases of limb occlusions. Furthermore, post-
operative instances of reduced limb flow typically were
managed with combined interventions. Mechanical throm-
bectomy with balloon-tipped catheters was not commonly
used in either the intraoperative or postoperative setting
and may be relatively contraindicated because of the risk of
precipitating endograft migration. Of the 28 postoperative
interventions, femorofemoral bypass was necessitated in six
cases (21%). One additional femorofemoral bypass was
necessitated during. Thus, of a total of 17 patients with
limb thromboses, limb patency was achieved in 10 patients
(59%) with endovascular techniques. In the remaining
seven cases (41% of all limb thromboses), a femorofemoral
bypass was necessitated after failed endovascular interven-
tions (four patients) or was done as the primary procedure
without an initial endovascular approach (three patients).
Repeated interventions were rarely necessitated (1%).
In spite of the incidence of limb dysfunction reported in
this Phase II cohort, only one patient had an amputation,
and this could be attributed to local femoral artery issues,
not a technical or patency problem with the graft limb.
The results of analysis for identification of variables
predictive of reduced graft limb flow revealed a statistical
association with increased risk for limb problems in female
patients, most likely related to access and oversizing issues.
Velazquez et al7 showed that there are gender-related
differences in infrarenal aortic aneurysm morphologic fea-
tures, including (but not limited to) significantly reduced
iliac artery size in women. In this work, we show that when
graft limb diameters were oversized by approximately 4 mm
compared with the ipsilateral common iliac artery, the
incidence rate of limb dysfunction was increased 12 fold.
Presumably, the mechanism of reduced limb flow in over-
sized graft limbs is a consequence of fabric pleats and
compliance mismatch. The trend toward reduced limb flow
in the presence of coexistent infrainguinal arterial occlusive
disease (poor runoff) may be attributable to high resistance
outflow. This trend also may potentially be attributed to an
association between infrainguinal disease and suprainguinal
disease. That is, patients with large calcified plaques in the
femoral arteries may often have a similar degree of calcified
occlusive disease within the common iliac arteries.
The assessment of a potential intraoperative limb dys-
function was often made on the basis of a perceived prob-
lem. However, on the basis of the data, the need for
intraoperative intervention could be interpreted as proba-
bly underestimated, given that the rate of limb problems in
the absence of any intraoperative treatment was as high as
16%. The rate of postoperative intervention in patients
treated during surgery was 4%, whereas the rate in those not
treated during surgery was 16%, suggesting that the intra-
operative assessment of the operating team was likely on
target and thus indirectly suggesting a beneficial affect for
preventative intraoperative interventions. Clearly, the cen-
ters performing more implants were more likely to perform
a greater percentage of intraoperative interventions. This
suggests that as investigators gained more experience, they
were more likely to support the limbs at the time of implan-
tation in an educated effort to avoid postoperative limb
problems. Interestingly, centers that performed less intra-









Graft limb diameter .98
Hypertension .78
Investigator experience .15
Limb diameter oversize .09
Common iliac diameters .36
Arterial occlusive disease .08
Procedural antiplatelet use .64
Superior neck diameter .50
Table III. Effect of limb oversizing relative to ipsilateral
common iliac artery attachment site
Iliac diameter oversized by:
No. of patients in whom limb
intervention was necessitated
No Yes Total
3.5 to 4.4 mm 1 12 13
2.5 to 3.4 mm 19 19 38
1.5 to 2.4 mm 56 20 76
0.5 to 1.4 mm 57 32 89
0 to 0.4 mm 15 10 25
Total 148 93 241*
Size 4, P  .011.
*One patient excluded because iliac sizing data were incomplete.
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operative interventions did not observe significantly higher
postoperative adverse limb events.
We believe recommendation of the practice of rou-
tinely supporting (stenting) Ancure graft limbs is prema-
ture, although the data presented in this work may be used
to support such a recommendation. One should keep in
mind, however, that 60% of the patients maintained limb
patency without adjunctive intervention. Longer term re-
sults are needed to truly determine the need for limb
support. Placing a stent to support an Ancure limb effec-
tively creates an endoskeleton, and although no instances of
Ancure type III endoleaks have been identified to date
(2-year to 4-year follow-up), other endografts with an
endoskeletal design with sutures and thinner fabric have
proven vulnerable to friction and fabric erosion, over time
producing late endoleaks.8,9 Whether the mechanism of
failure is the result of the endoskeletal design model itself or
the suturing of stents to fabric remains to be determined.
However, the Ancure device is unlikely to be negatively
impacted by Wallstents placed within its limbs. At this time,
placing an unsutured stent inside an Ancure limb appears to
be a safe practice but may not be necessitated routinely.
Routinely placing bilateral stents within the Ancure limbs
significantly inflates the cost of this technology and would
not be necessary on the basis of these data in most patients
(60%) in the given follow-up interval. Calculation of the
Fig 6. Case volume versus percentage of intraoperative interventions per center. Depicted is number of implants
performed at center expressed as percent of total patients on X-axis versus intraoperative (io) interventions as ratio of
all interventions on Y-axis.
Fig 7. Case volume versus percentage of postoperative interventions per center. Depicted is case volume performed at
center expressed as percent of total cases on X-axis versus postoperative (PO) interventions as ratio of all interventions
on Y-axis.
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added expense of supporting all endolegs at the time of
initial deployment compared with the anticipated expense
of delayed primary interventions necessary in potentially as
many as 40% of patients would be noteworthy, however.
The cost of prophylactic stent placement is approximately
$11,000 per patient. However, one could easily offset this
cost against the cost of readmission for a potentially oc-
cluded limb. Beyond cost, however, presumably real issues
of morbidity, which are less predictive and difficult to
quantify, are associated with delayed intervention other
than amputation. Clearly, a subset of patients appears to
benefit from prophylactic stent placement. This subset
includes women with small iliac arteries, instances of graft
limb oversizing (compared with the ipsilateral iliac artery
attachment site), and patients with coexistent infrainguinal
arterial occlusive disease. In addition, any case in which the
operating team believes that technical success has not been
satisfactorily achieved should likely not leave the operating
room until any real or perceived limb flow problem is
completely resolved. We would advocate a methodic intra-
operative assessment of the graft limbs. After endograft
deployment and routine ballooning, the completion arte-
riogram should be performed after all stiff wires have been
removed. Although stiff wires are essential for device access
and deployment because they straighten the iliac arteries,
removing them before the final arteriogram occasionally
uncovers instances of kinks, twists, pleats, and compression
resulting in stenoses. In addition to the standard antero-
posterior projections, bilateral oblique imaging may be a
useful adjunct. When the threat of reduced limb flow
remains unresolved, intraoperative pullout pressure mea-
surements or intravascular ultrasound scan may detect limb
dysfunction.2,10 We would certainly endorse supporting
graft limbs when arteriographic/intravascular ultrasound
scan or physiologic documentation of limb dysfunction has
been found.
Unresolved technical points include the routine use of
bilateral stents to avoid compression of an unsupported
limb and the need to support an entire limb, as opposed to
the portion of the limb where the problem exists. The
authors favor supporting only the portion of the limb where
an identifiable problem exists and placement of bilateral
stents only when bilateral limb problems arise. Further-
more, because this report is an analysis of limb interventions
associated with the use of the first generation deployment
system, current results with the Ancure deployment system
may not be strictly comparable. The lessons learned from
Phase II and more aggressive intraoperative stenting may
have significantly reduced the incidence of postoperative
intervention with the newer Ancure system.
Furthermore, recognition that supported and unsup-
ported stent grafts are associated with limb kinking is
important, although direct comparison suggests than an
unsupported limb may be more than 15 times more likely
to need intervention because of kinking than a supported
one in short-term follow-up.1 That unsupported endograft
limbs are susceptible to reduced flow and dysfunction early
has been suggested and that supported limbs are in fact also
vulnerable, but perhaps later on.11,12
Lastly, because most postoperative limb problems
(80%) occurred during the first 6 months after implanta-
tion, the early follow-up surveillance should not only con-
centrate on endoleak detection and aneurysm sac size but
may justifiably include focused questions regarding claudi-
cation and a noninvasive assessment of graft limb flow with
duplex scanning, segmental pressures, ankle-brachial indi-
ces, and pulse volume recordings. The determination of the
most ideal technique to identify a vulnerable or failing
endograft limb is not addressed with these data and is
beyond the scope of this report. However, physicians
should remain sensitized to the potential for reduced limb
Fig 8. Percentage of intraoperative versus postoperative interventions per center. Depicted is number of intraopera-
tive interventions (Io) at center expressed as percent of total interventions on X-axis versus postoperative (Po)
interventions as percent of all interventions on Y-axis.
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flow occurring both during and after surgery and necessi-
tating adjunctive interventions.
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